Trending Now
Seelos Therapeutics Inc. (NASDAQ:SEEL) And Duke University Enter Sponsored Research Agreement...
Seelos Therapeutics Inc. (NASDAQ:SEEL) and Duke University have entered a Sponsored Research Agreement (SRA). The agreement is for using an MPTP-induced Parkinson's Diseases (PD)...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Portfolio Fitness to Close Out the Year (PTON, PLNT, BTDG, NLS)
The fitness space has been outperforming expectations as the pandemic curtails in-person activities, crushing many industries, including gyms and fitness facilities. But the need...
MAKE IT MODERN
LATEST REVIEWS
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Submits sNDA For Approval Of NUPLAZID (pimavanserin)...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has announced the submission of a supplemental new drug application (sNDA) seeking approval from the FDA for its NUPLAZID (pimavanserin)...
MAKE IT MODERN
PERFORMANCE TRAINING
Financial markets do not seem to be stressed (DIS, CAR, K)
The market gapped down this morning in continued risk-off sentiment although there has been a small pop on the open. The QQQ’s...
Portage Biotech (PRTG): Wild Ride Continues, But Uncertainty Looms
Portage Biotech (PRTG) has been on a rollercoaster lately, with shares closing up a dramatic 118% on August 27th, only to give...
Wall Street (S&P 500 Index) is all but confused
It has been a mixed day today for the SPY trade. In many ways it's been trading like a Monday though it's...
Atossa Therapeutics Inc (NASDAQ:ATOS) Reports Results Of Phase 1 Clinical Trial Of Its Nasal...
Atossa Therapeutics Inc (NASDAQ:ATOS) posted AT-301 Nasal Spray Phase 1 clinical trial results in Q1 2021.
Nasal spray for patients with COVID-19
The company reported no...
BYND Cannasoft (BCAN): A Small-Cap Enterprise with Exceptional Growth Prospects in the Booming Sextech...
*Sponsored on behalf of BYND Cannasoft
As a promising small-cap enterprise operating in the sextech industry, BYND Cannasoft Enterprises...
MAKE IT MODERN
